Integra LifeSciences Holdings · IART.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $3.60B − (Liabilities $2.56B + Equity $1.04B) = $0.00 · in balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$235.05M
6.5%
-$11.33M
-4.6%
Assets
Receivables
$278.85M
7.7%
$6.48M
2.4%
Assets
Inventory
$492.74M
13.7%
$63.65M
14.8%
Assets
Other current assets
$124.22M
3.4%
$17.57M
16.5%
Assets
PPE
$584.90M
16.2%
$35.14M
6.4%
Assets
Goodwill & intangibles
$1.75B
48.6%
-$554.72M
-24.1%
Assets
Other
$136.43M
3.8%
$7.80M
6.1%
Liabilities + Equity
Short-term debt
$140.57M
3.9%
-$481.05M
-77.4%
Liabilities + Equity
Long-term debt
$1.73B
48.0%
$533.54M
44.6%
Liabilities + Equity
Other liabilities
$688.41M
19.1%
$13.90M
2.1%
Liabilities + Equity
Equity
$1.04B
29.0%
-$501.82M
-32.5%